FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:1440-1441 May 11, 2000 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

In the past decade, many new drugs have become available for patients with diabetes mellitus. The sulfonylurea drugs and metformin have been joined by disaccharidase inhibitors, meglitinides, and thiazolidinediones. Several new insulin preparations have been developed, with a wide spectrum of times of peak action and durations of action. Insulin lispro is the first of these to reach the market. In the face of this impressive progress in drug treatment of diabetes, the article by Chandalia et al. in this issue of the Journal¹ serves as a timely reminder that, until the advent of insulin in the 1920s, the only . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Barner, C., Wylie-Rosett, J., Gans, K. (2001). WAVE: A Pocket Guide for a Brief Nutrition Dialogue in Primary Care. The Diabetes Educator 27: 352-362